222 related articles for article (PubMed ID: 35821284)
1. Cancer vaccine strategies using self-replicating RNA viral platforms.
Dailey GP; Crosby EJ; Hartman ZC
Cancer Gene Ther; 2023 Jun; 30(6):794-802. PubMed ID: 35821284
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials of self-replicating RNA-based cancer vaccines.
Morse MA; Crosby EJ; Force J; Osada T; Hobeika AC; Hartman ZC; Berglund P; Smith J; Lyerly HK
Cancer Gene Ther; 2023 Jun; 30(6):803-811. PubMed ID: 36765179
[TBL] [Abstract][Full Text] [Related]
3. Next generation self-replicating RNA vectors for vaccines and immunotherapies.
Aliahmad P; Miyake-Stoner SJ; Geall AJ; Wang NS
Cancer Gene Ther; 2023 Jun; 30(6):785-793. PubMed ID: 35194198
[TBL] [Abstract][Full Text] [Related]
4. Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Amano T; Yu H; Amano M; Leyder E; Badiola M; Ray P; Kim J; Ko AC; Achour A; Weng NP; Kochba E; Levin Y; Ko MSH
bioRxiv; 2022 Sep; ():. PubMed ID: 36263074
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
6. Controllable self-replicating RNA vaccine delivered intradermally elicits predominantly cellular immunity.
Amano T; Yu H; Amano M; Leyder E; Badiola M; Ray P; Kim J; Ko AC; Achour A; Weng NP; Kochba E; Levin Y; Ko MSH
iScience; 2023 Apr; 26(4):106335. PubMed ID: 36968065
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.
Cheng WF; Hung CH; Chai CY; Hsu KF; He L; Ling M; Wu TC
J Virol; 2001 Mar; 75(5):2368-76. PubMed ID: 11160740
[TBL] [Abstract][Full Text] [Related]
8. Veterinary Replicon Vaccines.
Hikke MC; Pijlman GP
Annu Rev Anim Biosci; 2017 Feb; 5():89-109. PubMed ID: 27860492
[TBL] [Abstract][Full Text] [Related]
9. Self-Amplifying RNA Viruses as RNA Vaccines.
Lundstrom K
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698494
[TBL] [Abstract][Full Text] [Related]
10. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
11. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
12. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.
McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN
Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821
[TBL] [Abstract][Full Text] [Related]
13. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
[TBL] [Abstract][Full Text] [Related]
14. Self-replicating alphavirus RNA vaccines.
Ljungberg K; Liljeström P
Expert Rev Vaccines; 2015 Feb; 14(2):177-94. PubMed ID: 25269775
[TBL] [Abstract][Full Text] [Related]
15. Bioengineering of Novel Non-Replicating mRNA (NRM) and Self-Amplifying mRNA (SAM) Vaccine Candidates Against SARS-CoV-2 Using Immunoinformatics Approach.
Bhattacharya M; Sharma AR; Ghosh P; Patra P; Patra BC; Lee SS; Chakraborty C
Mol Biotechnol; 2022 May; 64(5):510-525. PubMed ID: 34981440
[TBL] [Abstract][Full Text] [Related]
16. Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena.
Chavda VP; Bezbaruah R; Athalye M; Parikh PK; Chhipa AS; Patel S; Apostolopoulos V
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458489
[TBL] [Abstract][Full Text] [Related]
17. Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
Hawman DW; Meade-White K; Clancy C; Archer J; Hinkley T; Leventhal SS; Rao D; Stamper A; Lewis M; Rosenke R; Krieger K; Randall S; Khandhar AP; Hao L; Hsiang TY; Greninger AL; Gale M; Berglund P; Fuller DH; Rosenke K; Feldmann H; Erasmus JH
EBioMedicine; 2022 Sep; 83():104196. PubMed ID: 35932641
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and phenotypic analysis of CD8+ T cell responses after priming with alphavirus replicons and homologous or heterologous booster immunizations.
Knudsen ML; Ljungberg K; Kakoulidou M; Kostic L; Hallengärd D; García-Arriaza J; Merits A; Esteban M; Liljeström P
J Virol; 2014 Nov; 88(21):12438-51. PubMed ID: 25122792
[TBL] [Abstract][Full Text] [Related]
19. Self-Amplifying Pestivirus Replicon RNA Encoding Influenza Virus Nucleoprotein and Hemagglutinin Promote Humoral and Cellular Immune Responses in Pigs.
Démoulins T; Ruggli N; Gerber M; Thomann-Harwood LJ; Ebensen T; Schulze K; Guzmán CA; McCullough KC
Front Immunol; 2020; 11():622385. PubMed ID: 33584723
[TBL] [Abstract][Full Text] [Related]
20. Alphavirus vectors and vaccination.
Rayner JO; Dryga SA; Kamrud KI
Rev Med Virol; 2002; 12(5):279-96. PubMed ID: 12211042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
